# Limoneira CO: overview

LMNR · Nasdaq · CIK 1342423 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/lmnr.md) · [Financials](/companies/lmnr/financials.md) · [Filings](/companies/lmnr/filings.md) · [Insiders](/companies/lmnr/insiders.md)

Latest reported revenue: [$42.2m](/filings/0001342423-26-000031.md) for Q3 FY2026, three months to 2026-07-31, from the 10-Q filed Sep 9, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001342423-26-000031).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q4 FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [42.5 d](/filings/0001342423-25-000039.md) | [32.9](/filings/0001342423-26-000013.md) | [33.6](/filings/0001342423-26-000023.md) | [45.9](/filings/0001342423-26-000031.md) | [41.3 d](/filings/0001342423-25-000039.md) | [16.8](/filings/0001342423-26-000013.md) | [22.5](/filings/0001342423-26-000023.md) | [42.2](/filings/0001342423-26-000031.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(6.5%) d](/filings/0001342423-25-000039.md) | [(16.3%)](/filings/0001342423-26-000013.md) | [(10.0%)](/filings/0001342423-26-000023.md) | [(1.4%)](/filings/0001342423-26-000031.md) | [(26.8%) d](/filings/0001342423-25-000039.md) | [(63.0%)](/filings/0001342423-26-000013.md) | [(96.3%)](/filings/0001342423-26-000023.md) | [(7.0%)](/filings/0001342423-26-000031.md) |
| Net margin | % | [(4.4%) d](/filings/0001342423-25-000039.md) | [(9.4%)](/filings/0001342423-26-000013.md) | [(10.0%)](/filings/0001342423-26-000023.md) | [(1.9%)](/filings/0001342423-26-000031.md) | [(21.0%) d](/filings/0001342423-25-000039.md) | [(56.3%)](/filings/0001342423-26-000013.md) | [(95.1%)](/filings/0001342423-26-000023.md) | [(7.1%)](/filings/0001342423-26-000031.md) |
| Diluted EPS | $ per share | not reported | [(0.18)](/filings/0001342423-26-000013.md) | [(0.20)](/filings/0001342423-26-000023.md) | [(0.06)](/filings/0001342423-26-000031.md) | not reported | [(0.53)](/filings/0001342423-26-000013.md) | [(1.20)](/filings/0001342423-26-000023.md) | [(0.17)](/filings/0001342423-26-000031.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-10-31) | FY2022 (2022-10-31) | FY2023 (2023-10-31) | FY2024 (2024-10-31) | FY2025 (2025-10-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [161](/filings/0001342423-23-000037.md) | [179](/filings/0001342423-24-000035.md) | [174](/filings/0001342423-25-000039.md) | [186](/filings/0001342423-25-000039.md) | [154](/filings/0001342423-25-000039.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(3.9%)](/filings/0001342423-23-000037.md) | [1.2%](/filings/0001342423-24-000035.md) | [6.2%](/filings/0001342423-25-000039.md) | [(3.3%)](/filings/0001342423-25-000039.md) | [(13.3%)](/filings/0001342423-25-000039.md) |
| Net margin | % | [(2.1%)](/filings/0001342423-23-000037.md) | [(0.1%)](/filings/0001342423-24-000035.md) | [5.4%](/filings/0001342423-25-000039.md) | [4.2%](/filings/0001342423-25-000039.md) | [(10.4%)](/filings/0001342423-25-000039.md) |
| Diluted EPS | $ per share | [(0.23)](/filings/0001342423-23-000037.md) | [(0.04)](/filings/0001342423-24-000035.md) | [0.50](/filings/0001342423-25-000039.md) | [0.40](/filings/0001342423-25-000039.md) | [(0.93)](/filings/0001342423-25-000039.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/lmnr/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Global Alpha Capital Management Ltd.](/funds/1584691.md) | 2026-06-30 | $38.1m | 2,898,549 |  | Reduced −27,718 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $15.1m | 1,147,405 |  | Added +40,280 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $9.4m | 715,090 |  | Reduced −73,052 |
| [FIRST WILSHIRE SECURITIES MANAGEMENT INC](/funds/732847.md) | 2026-06-30 | $7.7m | 586,536 |  | Added +8,477 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $6.8m | 517,570 |  | New +517,570 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $5.4m | 414,572 |  | Reduced −2,225 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $4.9m | 369,925 |  | Reduced −58,680 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $4.5m | 346,289 |  | Added +12,790 |
| [Peapod Lane Capital LLC](/funds/2050979.md) | 2026-06-30 | $4.5m | 340,880 |  | Added +92,537 |
| [Riverwater Partners LLC](/funds/1882572.md) | 2026-06-30 | $4.4m | 337,437 |  | Added +8,253 |

## Recent filings

[All 918 filings](/companies/lmnr/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 16:15 ET | [8-K](/filings/0001104659-26-118160.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-118160 |
| 2026-09-09 | 16:03 ET | [10-Q](/filings/0001342423-26-000031.md) | Quarterly report, period 2026-07-31 | 0001342423-26-000031 |
| 2026-09-09 | 16:02 ET | [8-K](/filings/0001342423-26-000030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001342423-26-000030 |
| 2026-08-17 | 16:31 ET | [8-K](/filings/0001104659-26-097890.md) | 1.01 Entry into a material agreement; 2.06 Material impairments; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-097890 |
| 2026-06-18 | 16:02 ET | [8-K](/filings/0001104659-26-075714.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-075714 |
| 2026-06-09 | 16:03 ET | [10-Q](/filings/0001342423-26-000023.md) | Quarterly report, period 2026-04-30 | 0001342423-26-000023 |
| 2026-06-09 | 16:02 ET | [8-K](/filings/0001342423-26-000022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001342423-26-000022 |
| 2026-04-20 | 16:01 ET | [8-K](/filings/0001104659-26-045476.md) | 1.01 Entry into a material agreement; 2.06 Material impairments; 9.01 Financial statements and exhibits | 0001104659-26-045476 |
| 2026-04-15 | 16:22 ET | [8-K](/filings/0001104659-26-043817.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-043817 |
| 2026-03-27 | 16:00 ET | [8-K](/filings/0001104659-26-036074.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-036074 |

## Latest annual report

[Form 10-K for the fiscal year ended Oct 31, 2025](/filings/0001342423-25-000039.md), filed Dec 23, 2025.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1342423
- Tickers: LMNR
- Exchange: Nasdaq
- SIC code: 100 Agricultural Production-Crops
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:19 ET. No prices; not investment advice.